About UMGCC

2008-2009 Fact Sheet

Overview:

The University of Maryland Marlene and Stewart Greenebaum Cancer Center is designated by the National Cancer Institute as one of the top cancer centers in the country. We offer innovative approaches to diagnosing and treating all types of cancer, serving patients throughout Maryland and the Mid-Atlantic region. Our physicians and scientists conduct cutting-edge research to bring the latest advances in cancer treatment directly to our patients.

National Recognition:

National Cancer Institute-designated Cancer Center
U.S. News & World Report's Top 50 Cancer Centers
Blue Cross Blue Shield Center of Distinction – Complex and Rare Cancers

Outstanding Patient Care:

At a Glance
45,000	Patient visits annually
125	Clinical trials
152	Physicians and researchers
$48.1 M	Research funding

A team approach to care – where specialists from all cancer disciplines work together to develop individualized treatment plans for each patient

Minimally invasive treatment options – including Trilogy for radiation therapy, da Vinci robot-assisted surgery and the newest, targeted chemotherapy drugs
Patient-focused Stoler Pavilion outpatient center – designed for patients' comfort and convenience, with flat-screen TVs and Internet access
Top-rated nursing staff – specially trained in cancer care and consistently rated "outstanding" on patient satisfaction surveys
Support services for patients – including full-time patient navigator, image renewal center and genetic counseling
Community outreach – free breast and cervical cancer screenings for uninsured, low-income Baltimore residents funded by the Maryland Cigarette Restitution Fund Program

Scientific Excellence:

Major breakthroughs in cancer research – such as Dr. Angela H. Brodie's discovery of aromatase inhibitors, a new class of drugs for treating women with breast cancer
Clinical trials – 125 active studies offering patients promising therapies, often years before they are commercially available
Active translational research program – designed to bring scientific discoveries rapidly from the laboratory to the patient's bedside
State-of-the-art laboratories – where our researchers are developing cancer vaccines, novel cancer-fighting agents and new combination therapies
Commitment to addressing cancer disparities – with research focused on improving access to care and treatment outcomes for minority populations
Major partnerships – with the state of Maryland, the National Cancer Institute and private industry

This page was last updated on: October 31, 2008.